).
consider the consequences of this relation on the management of VTE (primary and secondary prevention and diagnostic approach).
Why May Infectious Diseases Enhance the Risk of VTE?
Acute and chronic infectious diseases result from both the direct action of pathogens and the somehow deleterious antimicrobial immune response. The inflammation pathway is triggered by the contact between (1) pathogens or infected cells and (2) the immune cells (polymorphonuclears, monocytes, macrophages, lymphocytes). The consequences of this contact are multiple, featuring immune cell activation, inflammation-associated protein synthesis by the liver, onset of fever, and modification of the coagulation and fibrinolysis pathways.
Indeed, it has been shown that lipopolysaccharides, tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, and complement fractions enhanced the exposition of tissue factor (TF) by endothelial cells and monocytes/macrophages. [3] [4] [5] It has been observed that in septic patients, tissue factor pathway inhibitor (TFPI) plasma levels were decreased, 6 as well as in children with meningococcal sepsis. 7 Interestingly, it has been shown that omptins, outer membrane aspartyl proteases associated with gram-negative bacteria such as Yersinia pestis, can proteolytically inactivate TFPI. 8 This led to a clinical trial assessing if the administration of recombinant TFPI (tifacogin) was useful in septic patients, but these trials failed to show any beneficial effects. 9, 10 Moreover, antithrombin (AT) plasma levels are decreased in septic patients, and recombinant AT is routinely used for patients with disseminated intravascular coagulopathy and sepsis. On the other hand, it has been shown that TNF-α, tumor growth factor (TGF)-β, and IL-1 enhanced the synthesis by endothelial cells of plasminogen activator inhibitor-1 (PAI-1), and high levels of PAI-1 are associated with severity and mortality in patients with severe sepsis. 11 In ►Fig. 1, we summarize the possible interplay between these inflammatory and thrombosis mechanisms. The different studies show that the inflammatory process and the coagulation and fibrinolysis processes share redundant and common pathways, explaining why sepsis is associated with thrombosis.
Which Infectious Diseases Carry a Risk of VTE?
Acute Infections
As it is often difficult to draw the line between chronic infectious diseases and recurring acute infections, we shall first briefly consider acute infections. The association between acute infection and risk of VTE is well established and acute infections often figure in the list of triggering circumstances for which thromboprophylaxis should be considered. It should be noted that the consensus recommendations 12 are not particularly precise in their definition of infections carrying a risk of VTE. Severe sepsis is often invoked and severe infections are pointed at, but exact definitions are lacking and there is no exhaustive list of the different infections implicated. In the risk assessment models reviewed by Samama et al, 13 we find the terms "severe acute infection" and "bacterial infection" without further precision. Likewise, in the epidemiological analysis of the MEDENOX therapeutic trial, 14 in which acute infection was found to be an independent risk factor for VTE, the terms employed are rather unspecific (e.g., "acute infectious disease"). If clinically severe Fig. 1 A summary of the possible interplay between inflammatory and thrombosis mechanisms in acute and chronic septic states. for a link between VTE and flu symptoms or positive influenza serology, but they analyzed only a small series of patients. It is therefore impossible to know whether this acute infectious disease is a VTE risk factor, even though it has also been described, without any convincing causal argument, in isolated clinical cases of VTE in young subjects, such as in a 16-year-old girl who developed a deep vein thrombosis (DVT) during an infection by H1N1.
17
Paradoxically, neither acute nor chronic infectious diseases appear directly in VTE risk assessment scores. Only the presence of an active cancer is retained as being a major risk factor for VTE. 18, 19 Given the methods used in constructing these scores 18 from multivariate modeling on a large series of patients, in which the simplest most informative model is sought by selecting variables, it can be concluded that while being a very common condition, acute infection is not a major risk factor and has low priority in VTE risk analysis in the presence of clinical suspicion of VTE. Nevertheless, an acute infection, or an acute episode of a chronic infection, rather than the underlying presence of chronic infection, seems to be the most common trigger of VTE.
20
Several infectious diseases commonly associated with VTE fall more in the field of acute infection but the analysis of such situations can illuminate the pathophysiological mechanisms of the association.
Among the cases of VTE in the immediate vicinity of a focus of infection, we should mention Lemierre syndrome, 21, 22 which combines severe tonsillitis, usually by Fusobacterium necrophorum, 23 jugular thrombosis in contact with the infected site, and septic embolism in the lung. This is a particular case in which the site of infection probably plays a predominant role in the genesis of thrombosis via endothelial cell injury. 23 This particular pathophysiology explains the possibility of VTE in the context of this infection in children or adolescents. 24 A somewhat closely related situation is the colonization following central venous catheterization. Often due to Staphylococcus spp, these infections may be complicated by both systemic dissemination and thrombosis of the catheterized vessel (mostly the subclavicular and jugular vein).
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Another particularly interesting case from a pathophysiological point of view is the association between VTE and varicella zoster virus (VZV) infections (chickenpox and shingles). This rare association can be explained by the combination of microcirculatory damage (including purpura and necrosis in severe forms) with superficial venous thrombosis, with sometimes extension to the deep venous system and pulmonary embolism as in the case described in a child.
26
The associated biological mechanism is most often described as a transient protein S deficiency. 26, 27 Cases have also been described in adults, but from the epidemiological point of view this association is very rare and not a public health issue. It is noteworthy that several studies identified chickenpox (in children) and shingles (in adults) as risk factors for arterial stroke, and that most of VZV encephalitis features small vessel viral vasculitis. Similarly, the arterial damage related to chronic infection with Coxiella burnetii has been the subject of numerous publications. 28 The mechanism is related to the vascular tropism of this intracellular bacterium with direct vessel injury (infected aneurysms). In contrast to these numerous and well-known arterial lesions, there are only a few scattered case reports describing VTE associated with Q fever, suggesting that the prothrombotic role of this chronic infection is only modest. 32 were used to estimate the annual incidence of VTE at between 0.5 and 3%, well above the annual incidence in a general population of the same age. The suggested thrombogenic mechanisms are diverse, combining prolonged bed rest, poor general condition, comorbidity, and the specific impact of HIV infection on hemostasis.
As for the cardiovascular risk linked to HIV, 33 the thrombogenic role of anti-HIV therapy, especially highly active antiretroviral therapy, was evoked but not found by CrumCianflone et al. 34 In this retrospective study of 465 patients, the 17 cases of HIV-VTE association had a median age of 36 years, a long HIV follow-up (median 10 years), and a very strong predominance of males (88%); when compared with patients without VTE, these patients had significantly lower CD4 cell counts, lower nadir CD4 counts, higher HIV viral load, and were more likely to have a diagnosis of AIDS. Among the triggering factors, the main one was the coexistence of an active infectious disease (usually opportunistic) at the time of the VTE episode in 60% of patients, with a wide variety of pathogens involved, including Staphylococcus aureus, Coccidioides immitis, Streptococcus pneumoniae, Cryptococcus The clinical implications of these numerous findings for HIV infection are important in relation to VTE. A drug-based thromboprophylaxis should be considered especially during severe acute infectious episodes arising in the aftermath of infection. In view of the respiratory symptoms, pulmonary embolism should also be considered in these patients. Conversely, the therapeutic management of an episode of VTE in an HIV patient needs to take into account the many potential drug-drug interactions and the risk of potentially severe iatrogenicity as in the six cases of skin necrosis occurring after the introduction of a vitamin K antagonist treatment for DVT in HIVþ patients with tuberculosis (TB).
The other main chronic viral diseases are hepatitis B and C. Studies have shown that actively hepatitis C virus (HCV)-infected patients were at higher risk of thrombotic events, mostly arterial; however, the risk was twice as high for all HCV-infected patients, and nearly four times higher if patients presented with cirrhosis.
37 Similar work has not been performed for chronic active hepatitis B virus infection, although the risk of portal thrombosis is well known. Cytomegalovirus (CMV) infection is usually a self-limiting disease in the immunocompetent host. In the immunocompromised patient, such as transplant recipients, chronic CMV reactivation is common, and may lead to pneumonia, colitis, retinitis, encephalitis, and graft rejection. It has also been observed that CMV reaction was a risk factor for VTE in kidney transplant. 38 Various mechanisms have been identified, such as endothelial cell infection causing vascular cell damage, lupus anticoagulant induction, and enhancement of factor VIII synthesis and secretion.
Tuberculosis and Other Chronic Bacterial Infections
The relationship between TB and VTE was mentioned in the context of HIV. TB is one of the world's major chronic infections, ubiquitously affecting both populations with poor access to health care and those with very heterogeneous health care systems. As in most associations between chronic infections and VTE, one can find many examples of clinical cases (especially in the recent literature) of the occurrence of an episode of VTE in a young patient with no risk factors and/ or in an atypical location. with a prevalence of VTE of 2.07% (1.62-2.59%). The odds ratio estimated for this population, after adjustment for major risk factors for VTE, major comorbidities, age, and sex, was 1.55 (95% CI 1.23-1.97, p < 0.001). These results suggest that TB is indeed an independent risk factor for VTE with important differences between ethnic groups, as TB and VTE was much more common in black subjects. Black ethnic groups therefore represent a population in which this association deserves further attention. Hospital mortality is much higher for TB patients with VTE (15%) than for patients without VTE (2.7%).
We showed in this study that there was no link between the localization of TB and the clinical form of VTE. In particular, the hypothesis of possible in-situ thrombosis in the lungs directly related to the pulmonary form of TB was not supported by our results. This suggests that the link between VTE and TB is due to more general mechanisms (activation of coagulation, venous stasis, and general poor health) rather than via localized mechanisms. Finally, we also showed that the hypothesis of a link induced by the frequent pulmonary imaging undergone by TB patients revealing cases of asymptomatic pulmonary embolism was not upheld by the data. Taken together, a VTE-TB association seems very likely, although in practice it may be partly underestimated due to the fact that health systems in developing countries that see the largest number of TB cases do not have easy access to VTE diagnostic tools. Considering other bacterial infections, Chlamydia has been suspected to be associated with a higher rate of cardiovascular events, and pathophysiological studies suggested that atherosclerosis could be enhanced by chronic Chlamydia spp infection. Some work also suggested that VTE may be associated with Chlamydia pneumoniae seropositivity.
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Parasitic Infections
For many other chronic infectious diseases, the relationship with VTE has not been studied or only little studied, with only sporadic clinical cases reported. This is particularly true for the parasitic infections rampant in less developed parts of the world. Hypereosinophilia due to a parasitic infection is a specific hematologic abnormality that may be associated with a hypercoagulable state.
51 However, beyond rare case reports, there is no clinical evidence for an association between the most common parasitic infection, malaria, and VTE. Malaria is mainly associated with disseminated intravascular coagulopathy or lesions of the microcirculation. 52, 53 There are little data on other parasitic or fungal infections.
Conclusion
The risk of VTE due to a chronic infection arises through a well-established link between inflammation and the Chronic Infection and Venous Thromboembolic Disease Epaulard et al. 647
regulation of coagulation. While the hemorrhagic consequences of this mechanism are clinically well documented for many infections, especially viral diseases (Ebola, etc.), the clinical consequences in terms of VTE (DVT and/or pulmonary embolism) are much less frequently studied and numerous unknowns persist. This is so for both chronic and acute infections. In practice, the biological, clinical, and epidemiological arguments seem coherent and consistent for recommending an estimation of risk and appraisal of thromboprophylaxis for patients presenting the two major chronic infectious diseases, HIV and TB. Overall, VTE risk assessment, in particular acute thrombogenic situations (prolonged bed rest, surgery, acute comorbidity, etc.), should take into account any concurrent chronic infection when considering the introduction of short-term thromboprophylaxis.
Other infections presenting a risk of VTE are usually acute pathologies and are almost always special cases with low overall VTE frequency (viral respiratory tropism, varicella zona, CMV, H1N1, etc.). For most of the major chronic infections, there is insufficient clinical and epidemiological data beyond the pathophysiology involving inflammation and acquired coagulation disorders.
There is a need for systematic reviews of the literature, with no language restriction, before implementing largescale epidemiological studies in this wide-ranging field.
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